Machine learning for the prediction of safe and biologically active organophosphorus molecules

• URL: http://arxiv.org/abs/2302.10952v1
• Date: Tue, 21 Feb 2023 19:12:35 GMT
• Title: Machine learning for the prediction of safe and biologically active organophosphorus molecules
• Authors: Hang Hu, Hsu Kiang Ooi, Mohammad Sajjad Ghaemi, Anguang Hu
• Abstract summary: We propose a framework of Recurrent Neural Networks (RNN) with an attention model to sample the chemical space of organophosphorus molecules. The goal is to predict molecules with similar biological action modes as organophosphorus pesticides or chemical warfare agents yet less toxic to humans.
• Score: 2.169755083801688
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Drug discovery is a complex process with a large molecular space to be considered. By constraining the search space, the fragment-based drug design is an approach that can effectively sample the chemical space of interest. Here we propose a framework of Recurrent Neural Networks (RNN) with an attention model to sample the chemical space of organophosphorus molecules using the fragment-based approach. The framework is trained with a ZINC dataset that is screened for high druglikeness scores. The goal is to predict molecules with similar biological action modes as organophosphorus pesticides or chemical warfare agents yet less toxic to humans. The generated molecules contain a starting fragment of PO2F but have a bulky hydrocarbon side chain limiting its binding effectiveness to the targeted protein.

Related papers

• Navigating Chemical Space with Latent Flows [20.95884505685799]
  We propose a new framework, ChemFlow, to traverse chemical space through navigating the latent space learned by molecule generative models through flows. We validate the efficacy of ChemFlow on molecule manipulation and single- and multi-objective optimization tasks under both supervised and unsupervised molecular discovery settings.
  arXiv  Detail & Related papers  (2024-05-07T03:55:57Z)
• Generative Active Learning for the Search of Small-molecule Protein Binders [87.106635995213]
  We introduce LambdaZero, a generative active learning approach to search for synthesizable molecules. LambdaZero learns to search over the vast space of molecules to discover candidates with a desired property. We apply LambdaZero with molecular docking to design novel small soluble molecules that inhibit the enzyme Epoxide Hydrolase 2 (sEH) LambdaZero discovers novel scaffolds of synthesizable, drug-like inhibitors for sEH.
  arXiv  Detail & Related papers  (2024-05-02T16:39:21Z)
• STRIDE: Structure-guided Generation for Inverse Design of Molecules [0.24578723416255752]
  $textbfSTRIDE$ is a generative molecule workflow that generates novel molecules with an unconditional generative model guided by known molecules without any retraining. Our generated molecules have on average 21.7% lower synthetic accessibility scores and also reduce ionization potential by 5.9% of generated molecules via guiding.
  arXiv  Detail & Related papers  (2023-11-06T08:22:35Z)
• ChemSpaceAL: An Efficient Active Learning Methodology Applied to Protein-Specific Molecular Generation [0.0]
  We present a computationally efficient active learning methodology that requires evaluation of only a subset of the generated data. We demonstrate the applicability of this methodology to targeted molecular generation by fine-tuning a GPT-based molecular generator toward a protein with FDA-approved small-molecule inhibitors, c-Abl kinase. Remarkably, the model learns to generate molecules similar to the inhibitors without prior knowledge of their existence, and even reproduces two of them exactly.
  arXiv  Detail & Related papers  (2023-09-11T22:28:36Z)
• Functional-Group-Based Diffusion for Pocket-Specific Molecule Generation and Elaboration [63.23362798102195]
  We propose D3FG, a functional-group-based diffusion model for pocket-specific molecule generation and elaboration. D3FG decomposes molecules into two categories of components: functional groups defined as rigid bodies and linkers as mass points. In the experiments, our method can generate molecules with more realistic 3D structures, competitive affinities toward the protein targets, and better drug properties.
  arXiv  Detail & Related papers  (2023-05-30T06:41:20Z)
• Target Specific De Novo Design of Drug Candidate Molecules with Graph Transformer-based Generative Adversarial Networks [0.0]
  We propose an end-to-end generative system, DrugGEN, for the de novo design of drug candidate molecules. The system is trained using a large dataset of drug-like compounds and target-specific bioactive molecules. Using the open-access DrugGEN, it is possible to easily train models for other druggable proteins.
  arXiv  Detail & Related papers  (2023-02-15T18:59:27Z)
• Exploring Chemical Space with Score-based Out-of-distribution Generation [57.15855198512551]
  We propose a score-based diffusion scheme that incorporates out-of-distribution control in the generative differential equation (SDE) Since some novel molecules may not meet the basic requirements of real-world drugs, MOOD performs conditional generation by utilizing the gradients from a property predictor. We experimentally validate that MOOD is able to explore the chemical space beyond the training distribution, generating molecules that outscore ones found with existing methods, and even the top 0.01% of the original training pool.
  arXiv  Detail & Related papers  (2022-06-06T06:17:11Z)
• RetroGNN: Approximating Retrosynthesis by Graph Neural Networks for De Novo Drug Design [75.14290780116002]
  We train deep graph neural networks to approximate the outputs of a retrosynthesis planning software. Our approach finds molecules predicted to be more likely to be antibiotics while maintaining good drug-like properties and being easily synthesizable.
  arXiv  Detail & Related papers  (2020-11-25T22:04:16Z)
• Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning [75.95376096628135]
  We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space. We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
  arXiv  Detail & Related papers  (2020-04-26T21:40:03Z)
• CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models [74.58583689523999]
  We propose an end-to-end framework, named CogMol, for designing new drug-like small molecules targeting novel viral proteins. CogMol combines adaptive pre-training of a molecular SMILES Variational Autoencoder (VAE) and an efficient multi-attribute controlled sampling scheme. CogMol handles multi-constraint design of synthesizable, low-toxic, drug-like molecules with high target specificity and selectivity.
  arXiv  Detail & Related papers  (2020-04-02T18:17:20Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.